Literature DB >> 31059393

Role of US LI-RADS in the LI-RADS Algorithm.

Shuchi K Rodgers1, David T Fetzer1, Helena Gabriel1, James H Seow1, Hailey H Choi1, Katherine E Maturen1, Ashish P Wasnik1, Tara A Morgan1, Nirvikar Dahiya1, Mary K O'Boyle1, Yuko Kono1, Claude B Sirlin1, Aya Kamaya1.   

Abstract

The US Liver Imaging Reporting and Data System (LI-RADS) was released in 2017 and is the newest of the four American College of Radiology (ACR) LI-RADS algorithms. US LI-RADS provides standardized terminology, technical recommendations, and a reporting framework for US examinations performed for screening or surveillance in patients at risk for developing hepatocellular carcinoma (HCC). The appropriate patient population for screening and surveillance includes individuals who are at risk for developing HCC but do not have known or suspected cancer. This includes patients with cirrhosis from any cause and subsets of patients with chronic hepatitis B virus infection in the absence of cirrhosis. In an HCC screening or surveillance study, US LI-RADS recommends assigning two scores that apply to the entire study: the US category, which determines follow-up, and a visualization score, which communicates the expected level of sensitivity of the examination but does not affect management. Three US categories are possible: US-1 negative, a study with no evidence of HCC; US-2 subthreshold, a study in which an observation less than 10 mm is depicted that is not definitely benign; and US-3 positive, a study in which an observation greater than or equal to 10 mm or a new thrombus in vein is identified, for which diagnostic contrast material-enhanced imaging is recommended. Three visualization scores are possible: A (no or minimal limitations), B (moderate limitations), and C (severe limitations). ©RSNA, 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31059393      PMCID: PMC6542628          DOI: 10.1148/rg.2019180158

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  34 in total

1.  Prospective study of early detection for primary liver cancer.

Authors:  B Yang; B Zhang; Y Xu; W Wang; Y Shen; A Zhang; Z Xu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases.

Authors:  L Solmi; A M Primerano; L Gandolfi
Journal:  Am J Gastroenterol       Date:  1996-06       Impact factor: 10.864

Review 3.  Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Authors:  Kelly A Gebo; Geetanjali Chander; Mollie W Jenckes; Khalil G Ghanem; H Franklin Herlong; Michael S Torbenson; Samer S El-Kamary; Eric B Bass
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Authors:  Christoph Wald; Mark W Russo; Julie K Heimbach; Hero K Hussain; Elizabeth A Pomfret; Jordi Bruix
Journal:  Radiology       Date:  2013-02       Impact factor: 11.105

5.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 6.  Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.

Authors:  An Tang; Oussama Hallouch; Victoria Chernyak; Aya Kamaya; Claude B Sirlin
Journal:  Abdom Radiol (NY)       Date:  2018-01

Review 7.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

8.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

9.  Breast Imaging in the Era of Big Data: Structured Reporting and Data Mining.

Authors:  Laurie R Margolies; Gaurav Pandey; Eliot R Horowitz; David S Mendelson
Journal:  AJR Am J Roentgenol       Date:  2015-11-20       Impact factor: 3.959

10.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.

Authors:  Tomi Akinyemiju; Semaw Abera; Muktar Ahmed; Noore Alam; Mulubirhan Assefa Alemayohu; Christine Allen; Rajaa Al-Raddadi; Nelson Alvis-Guzman; Yaw Amoako; Al Artaman; Tadesse Awoke Ayele; Aleksandra Barac; Isabela Bensenor; Adugnaw Berhane; Zulfiqar Bhutta; Jacqueline Castillo-Rivas; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Lalit Dandona; Rakhi Dandona; Subhojit Dey; Daniel Dicker; Huyen Phuc; Donatus U. Ekwueme; Maysaa El Sayed Zaki; Florian Fischer; Thomas Fürst; Jamie Hancock; Simon I. Hay; Peter Hotez; Sun Ha Jee; Amir Kasaeian; Yousef Khader; Young-Ho Khang; Anil Kumar; Michael Kutz; Heidi Larson; Alan Lopez; Raimundas Lunevicius; Reza Malekzadeh; Colm McAlinden; Toni Meier; Walter Mendoza; Ali Mokdad; Maziar Moradi-Lakeh; Gabriele Nagel; Quyen Nguyen; Grant Nguyen; Felix Ogbo; George Patton; David M. Pereira; Farshad Pourmalek; Mostafa Qorbani; Amir Radfar; Gholamreza Roshandel; Joshua A Salomon; Juan Sanabria; Benn Sartorius; Maheswar Satpathy; Monika Sawhney; Sadaf Sepanlou; Katya Shackelford; Hirbo Shore; Jiandong Sun; Desalegn Tadese Mengistu; Roman Topór-Mądry; Bach Tran; Vasiliy Vlassov; Stein Emil Vollset; Theo Vos; Tolassa Wakayo; Elisabete Weiderpass; Andrea Werdecker; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Liguo Zhu; Christopher J. L. Murray; Mohsen Naghavi; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

View more
  11 in total

1.  Prevalence of extra-hepatic incidental findings on ultrasound screening for hepatocellular carcinoma.

Authors:  Allison Forrest; Sam Afshari; Nathan Franssen; Naiim Ali
Journal:  Abdom Radiol (NY)       Date:  2022-09-22

Review 2.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

3.  Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients.

Authors:  Wei-Bin Zhang; Si-Ze Hou; Yan-Ling Chen; Feng Mao; Yi Dong; Jian-Gang Chen; Wen-Ping Wang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

4.  Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.

Authors:  David T Fetzer; Travis Browning; Yin Xi; Takeshi Yokoo; Amit G Singal
Journal:  AJR Am J Roentgenol       Date:  2021-12-15       Impact factor: 6.582

5.  Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.

Authors:  Namkyu Kang; Jung Wha Chung; Eun Sun Jang; Sook-Hyang Jeong; Jin-Wook Kim
Journal:  Dig Dis Sci       Date:  2021-02-25       Impact factor: 3.199

6.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

7.  The role of imaging in surgical planning for liver resection: what the radiologist need to know.

Authors:  Andrea Agostini; Alessandra Borgheresi; Chiara Floridi; Marina Carotti; Giulia Grazzini; Francesco Pagnini; Susanna Guerrini; Pierpaolo Palumbo; Silvia Pradella; Gianpaolo Carrafiello; Marco Vivarelli; Andrea Giovagnoni
Journal:  Acta Biomed       Date:  2020-07-13

Review 8.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07

9.  Current status of image-based surveillance in hepatocellular carcinoma.

Authors:  Dong Hwan Kim; Joon-Il Choi
Journal:  Ultrasonography       Date:  2020-07-25

10.  Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions.

Authors:  Maria Cristina Chammas; André Leopoldino Bordini
Journal:  Ultrasonography       Date:  2021-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.